Neuland Laboratories (NEULANDLAB) Share Price Falls 2.47% Today
- October 1, 2026
- Posted by: Kunal Singla
- Category: News
Neuland Laboratories Share Price is trading lower today after the stock slipped 2.47% to Rs 20,865 from the previous close of Rs 21,392.65. The company’s market capitalisation stands at Rs 27,450.64 crore, placing it in the Large Cap category. For readers tracking Neuland Laboratories Share Price Today, the move is notable because the stock continues to command premium valuation multiples even after the decline. According to latest Univest figures, the price event is confirmed, but no company-specific catalyst is established. That makes the focus shift to price action, valuation, and how Neuland Laboratories Share Price compares with the broader Pharmaceuticals & Drugs set within Healthcare. Investors following Neuland Laboratories Stock News will also want to see whether the latest move changes how the market reads the company’s earnings quality, profitability and peer positioning.
According to Univest data, the price event is confirmed, but no company-specific catalyst is established. In that context, Neuland Laboratories Share Price Today is best read as a valuation-and-positioning story rather than a headline-driven event. The stock is trading at Rs 20,865, which keeps Neuland Laboratories Share Price in the spotlight for anyone scanning stock analysis, fundamental analysis and sector comparison. The session range so far shows that the price has moved within a tight band, and the opening block already makes clear that the day’s decline is measurable, but the reason is not stated by verified data. For investors searching Neuland Laboratories Share Price News, the key question is how the current price fits with earnings, book value and the industry benchmark.
Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 20,865 |
| Previous Close | Rs 21,392.65 |
| Today's Move | -Rs 527.65 (-2.47%) |
| Open | Rs 21,201.55 |
| High | Rs 21,278.9 |
| Low | Rs 20,862.15 |
| Market Capitalisation | Rs 27,450.64 crore |
| Market Cap Category | Large Cap |
Neuland Laboratories Share Price Today shows a decline of Rs 527.65, or 2.47%, with the stock last traded at Rs 20,865 versus the previous close of Rs 21,392.65. It opened at Rs 21,201.55, touched a high of Rs 21,278.90 and a low of Rs 20,862.15. The current price is close to the day’s low, which helps explain why the move is being tracked closely in Neuland Laboratories Stock News. The company sits in the Large Cap category with a market capitalisation of Rs 27,450.64 crore, so even a sub-3% move can add up to a meaningful shift in absolute value. In simple terms, Neuland Laboratories Share Price Today reflects a lower intraday print, but the verified data does not establish a fresh catalyst. That keeps the focus on price action and valuation, which links directly to Neuland Laboratories Fundamental Analysis.
For investors following Neuland Laboratories Share Price, the important facts are straightforward: the stock is lower than the previous close, it opened above the current level, and the day’s range has been relatively narrow. Neuland Laboratories Share Price Update also matters because the Large Cap label places the company among sizeable listed healthcare names, even though the market capitalisation is far below the industry’s largest peers. As of 01 October 2026 at 9:23:37 AM IST, Neuland Laboratories Share Price is trading with a visible intraday decline, and the next section looks at whether the fundamentals justify that premium starting point.
Neuland Laboratories (NEULANDLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 27,450.64 crore |
| P/E Ratio | 55.14x |
| P/B Ratio | 13.58x |
| ROE | 21.43% |
| ROCE | 27.5% |
| EPS | Rs 387.98 |
| Book Value Per Share | Rs 1,575.41 |
| Dividend Yield | 0.16% |
Neuland Laboratories (NEULANDLAB) fundamental metrics show P/E 55.14x, P/B 13.58x, ROE 21.43%, ROCE 27.5%. These figures provide context only and are not a buy or sell signal.
Neuland Laboratories has a market capitalisation of Rs 27,450.64 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 55.14x, P/B at 13.58x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.43% and ROCE of 27.5%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 387.98, book value per share of Rs 1,575.41, dividend yield of 0.16%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.02x, median ROE of 11.7%, median ROCE of 13.61%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 55.14x |
| Benchmark Median P/E | 32.02x |
| Benchmark Average P/E | 49.17x |
| Benchmark P/E Range | 3.4x to 688.17x |
| Company P/B Ratio | 13.58x |
| Benchmark Median P/B | 2.94x |
| Benchmark Average P/B | 4.37x |
| Company ROE | 21.43% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 27.5% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 27,450.64 crore |
| Benchmark Median Market Cap | Rs 770.9 crore |
| Benchmark Average Market Cap | Rs 14,358.25 crore |
Neuland Laboratories (NEULANDLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Neuland Laboratories (NEULANDLAB) has a P/E ratio of 55.14x, which is above the benchmark median of 32.02x, a difference of +72.2%. On its own, the P/E gap is a valuation reference point, not a trading call.
Neuland Laboratories (NEULANDLAB) has a ROE of 21.43%, which is above the benchmark median of 11.7%, a difference of +83.16%. Neuland Laboratories (NEULANDLAB) has a ROCE of 27.5%, which is above the benchmark median of 13.61%, a difference of +102.06%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,46,276.3 | 36.1 | 5.05 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,51,531.48 | 84.24 | 13.95 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,86,956.51 | 83.74 | 20.35 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,221.66 | 25.71 | 4.3 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,11,728.51 | 32.36 | 3.1 | 11.83 | 16 |
Neuland Laboratories (NEULANDLAB) has a P/E ratio of 55.14x compared with the displayed peer median of 36.1x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 21.43% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 27.5% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Neuland Laboratories (NEULANDLAB) has a market capitalisation of Rs 27,450.64 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Neuland Laboratories
- Neuland Laboratories Share Price is lower today by 2.47%, so the intraday move is being tracked closely.
- The company still trades at a high P/E and P/B, keeping valuation discussion active.
- ROE of 21.43% and ROCE of 27.5% support a strong profitability profile.
- Large Cap status and Rs 27,450.64 crore market capitalisation make the move meaningful.
- In the same industry, Neuland Laboratories Share Price stands above several peers on returns.
About Neuland Laboratories
Neuland Laboratories operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is known for pharmaceutical manufacturing and related drug development work, and its listed profile places Neuland Laboratories Share Price within a specialised part of the healthcare market. The exact revenue mix is not here, so the discussion stays with the verified sector and industry position. In market terms, Neuland Laboratories Market Cap and profitability ratios show that the company sits among premium-valued healthcare names. For readers comparing Neuland Laboratories Share Price with peers, the business profile matters because the stock is not a broad-market generic play; it is a focused pharma company within a competitive industry.
Track Neuland Laboratories Share Price on Univest
Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Investors can track Neuland Laboratories Share Price on Univest for live price updates, fundamental ratios, market capitalisation, 52-week levels and company news in one place. Neuland Laboratories Share Price Today can be reviewed alongside valuation metrics, peer comparison and broader healthcare context. Univest also helps readers follow Neuland Laboratories Stock News and Neuland Laboratories Share Price Update without switching across multiple sources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Neuland Laboratories Share Price falling today?
Ans. Neuland Laboratories Share Price is down 2.47% today, but the verified data does not establish a company-specific catalyst. The stock traded lower than the previous close, and the opening range shows the move developed during the morning session.
What is Neuland Laboratories Share Price today?
Ans. Neuland Laboratories Share Price is Rs 20,865 as of 01 October 2026 at 9:23:37 AM IST. It is lower than the previous close of Rs 21,392.65 and remains within today’s intraday range.
How much did Neuland Laboratories Share Price fall?
Ans. Neuland Laboratories Share Price fell Rs 527.65, or 2.47%, from the previous close. That move is meaningful because the company’s market capitalisation is Rs 27,450.64 crore, so even a moderate percentage change can shift value materially.
What is Neuland Laboratories market cap?
Ans. Neuland Laboratories Market Cap stands at Rs 27,450.64 crore. The company is classified as a Large Cap, which makes today’s decline relevant in absolute terms even though the percentage move is under 3%.
What valuation does Neuland Laboratories Share Price trade at?
Ans. Neuland Laboratories Share Price trades at a P/E of 55.14 and a P/B of 13.58. Both ratios are above the industry medians in the same industry, which keeps valuation central to stock analysis.
How strong are Neuland Laboratories profitability ratios?
Ans. Neuland Laboratories shows ROE of 21.43% and ROCE of 27.5%, both above the same-industry benchmark medians. Those figures indicate a comparatively strong profitability profile alongside the company’s premium valuation. The relevant peer median ROE is 11.7%.
How does Neuland Laboratories compare with peers?
Ans. Neuland Laboratories Share Price reflects a company with higher ROE and ROCE than several peers such as Sun Pharmaceutical Industries, Cipla and Dr. Reddy’s Laboratories, while its P/E sits below Divi’s Laboratories and Torrent Pharmaceuticals
Should investors track Neuland Laboratories Share Price on Univest?
Ans. Yes, Neuland Laboratories Share Price is worth tracking on Univest because the platform brings together live price movement, valuation ratios, market capitalisation, 52-week levels and company news in one place for quick review.
